Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery

Circulation

Volumn 100, Issue 8, 1999, Pages 849-854

  Chen, Donghui ^a   Asahara, Takayuki ^a   Krasinski, Kevin ^a   Witzenbichler, Bernhard ^a   Yang, Jihong ^a   Magner, Meredith ^a   Kearney, Marianne ^a   Frazier, William A ^c   Isner, Jeffrey M ^a   Andrés, Vicente ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angioplasty; Antibodies; Carotid arteries; Endothelium; Muscle, smooth

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTERY CALCIFICATION; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; ULTRASOUND;

EID: 0033600534     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.8.849     Document Type: Article

References (57)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest. 1983;49:208-215.
3. Gibbons GH, Dzau VJ. Molecular therapies for vascular diseases. Science. 1996;272:689-693.
4. Nikkari ST, Jarvelainen HT, Wight TN, Ferguson M, Clowes AW. Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am J Pathol. 1994;144:1348-1356.
5. Strauss BH, Chisholm RJ, Keeley FW, Gotlieb AI, Logan RA, Armstrong PW. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res. 1994;75:650-658.
6. Andrés V. Control of vascular smooth muscle cell growth and its implication in atherosclerosis and restenosis. Int J Mol Med. 1998;2: 81-89.
7. Carey DJ. Control of growth and differentiation of vascular cells by extracellular matrix proteins. Ann Rev Physiol. 1991;53:161-177.
8. Wight TN. The extracellular matrix and atherosclerosis. Curr Opin Lipidol. 1995;6:326-334.
9. Assoian RK, Marcantonio EE. The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis. J Clin Invest. 1996; 98:2436-2439.
10. Juliano RL, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol. 1993;120:577-585.
11. Savani RC, Wang C, Yang B, Zhang S, Kinsella MG, Wight TN, Stern R, Nance DW, Turley EA. Migration of bovine aortic smooth muscle cells after wounding injury: the role of hyaluronan and RHAMM. J Clin Invest. 1995;95:1158-1168.
12. Ruoslathi E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell. 1991;64:867-869.
13. Lawler J, Slayter HS, Coligan JE. Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. J Biol Chem. 1978;253:8609-8616.
14. McPherson J, Sage H, Bornstein P. Isolation and characterization of a glycoprotein secreted by aortic endothelial cells in culture: apparent identity with platelet thrombospondin. J Biol Chem. 1981;256: 11330-11336.
15. Reed MJ, Iruela-Arispe L, O'Brien ER, Truong T, LaBell T, Bornstein P, Sage EH. Expression of thrombospondins by endothelial cells: injury is correlated with TSP-1. Am J Pathol. 1995;147:1068-1080.
16. Jaffe EA, Ruggiero JT, Falcone DJ. Monocytes and macrophages synthesize and secrete thrombospondin. Blood. 1985;65:79-84.
17. Jaffe EA, Ruggiero JT, Leung LK, Doyle MJ, McKeown-Longo PJ, Mosher DF. Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Proc Natl Acad Sci U S A. 1983;80:998-1002.
18. Mumby SM, Abbott Brown D, Raugi D, Bornstein P. Regulation of thrombospondin secretion by cells in culture. J Cell Physiol. 1984; 120:280-288.
19. Frazier WA. Thrombospondins. Curr Opin Cell Biol. 1991;3:792-799.
20. Asch AS, Tepler J, Silbiger S, Nachman RL. Cellular attachment to thrombospondin: cooperative interactions between receptor systems. J Biol Chem. 1991;266:1740-1745.
21. Bagavandoss P, Wilks JW. Specific inhibition of endothelial cell proliferation by thrombospondin. Biochem Biophys Res Commun. 1990;170:867-872.
22. Taraboletti G, Roberts D, Liotta LA, Giavazzi R. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol. 1990;111: 765-772.
23. Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci U S A. 1990;87:6624-6628.
24. Iruela-Arispe ML, Bornstein P, Sage H. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci U S A. 1991;88:5026-5030.
25. O'Shea KS, Dixit VM. Unique distribution of extracellular matrix component thrombospondin in the developing mouse embryo. J Cell Biol. 1988;101:2737-2748.
26. Majack RA, Cook SC, Bornstein P. Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin. Proc Natl Acad Sci U S A. 1986;83:9050-9054.
27. Yabkowitz RY, Mansfield PJ, Ryan US, Suchard SJ. Thrombospondin mediates migration and potentiates platelet-derived growth factor-dependent migration of calf pulmonary artery smooth muscle cells. J Cell Physiol. 1993;157:24-32.
28. Tuszynski GP, Rothman LV, Murphy A, Siegler K, Knudsen KA. Thrombospondin promotes platelet aggregation. Blood. 1988;72: 109-115.
29. Dixit VM, Haverstick DM, O'Rourke KM, Hennessy SW, Grant GA, Santoro SA, Frazier WA. Monoclonal antibodies against human thrombospondin inhibit platelet aggregation. Proc Natl Acad Sci U S A. 1985;82:3472-3476.
30. Wight TN, Raugi GJ, Mumby SM, Bornstein P. Light microscopic immunolocation of thrombospondin in human tissues. J Histochem Cytochem. 1985;33:295-302.
31. Liau G, Winkles JA, Cannon MS, Kuo L, Chilian WM. Dietary-induced atherosclerotic lesions have increased levels of acidic FGF mRNA and altered cytoskeletal and extracellular matrix mRNA expression. J Vasc Res. 1993;30:327-332.
32. Van Zanten GH, de Graaf S, Slootweg PJ, Heijnen HFG, Connolly TM, de Groot PG, Sixma JJ. Increased platelet deposition on atherosclerotic coronary arteries. J Clin Invest. 1994;93:615-632.
33. Roth JJ, Gahtan V, Brown JL, Gerhard C, Swami VK, Rothman VL, Tulenko TN, Tuszynski GP. Thrombospondin-1 is elevated with both intimai hyperplasia and hypercholesterolemia. J Surg Res. 1998;74: 11-16.
34. Raugi GJ, Mullen JS, Barb DH, Okada T, Mayberg MR. Thrombospondin deposition in rat carotid artery injury. Am J Pathol. 1990; 137:179-185.
35. Botney MD, Kaiser LR, Cooper JD, Mecham RP, Parghi D, Roby J, Parks WC. Extracellular matrix protein gene expression in atherosclerotic hypertensive pulmonary arteries. Am J Pathol. 1992;140: 357-364.
36. Cuevas D, Gonzalez AM, Carceller F, Baird A. Vascular response to basic fibroblast growth factor when infused onto the normal adventitia or into the injured media of the rat carotid artery. Circ Res. 1991;69: 360-369.
37. Tsurumi Y, Murohara T, Krasinski K, Chen D, Witzenbichler B, Kearney M, Couffinhal T, Isner JM. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med. 1997;3:879-886.
38. Asahara T, Bauters C, Pastore C, Kearney M, Rossow S, Bunting S, Ferrara N, Symes JF, Isner JM. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimai hyperplasia in balloon-injured rat carotid artery. Circulation. 1995; 91:2793-2801.
39. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem. 1998; 273:18514-18521.
40. Pickering JG, Weir L, Rosenfield K, Stetz J, Jekanowski J, Isner JM. Smooth muscle cell outgrowth from human atherosclerotic plaque: implications for the assessment of lesion biology. J Am Coll Cardiol. 1992;20:1430-1439.
41. KIPI, an inhibitor of neointima formation in the rat carotid artery. J Clin Invest. 1997;99:2334-2341.
42. Miano JM, Vlasic N, Tota RR, Stemerman MB. Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury: a putative in vivo mechanism for autocrine growth. Arterioscler Thromb. 1993;13:211-219.
43. Wei GL, Krasinski K, Kearney M, Isner JM, Walsh K, Andrés V. Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. Circ Res. 1997;80:418-426.
44. Clowes AW, Clowes MM. Kinetics of cellular proliferation after arterial injury, II: inhibition of smooth muscle growth by heparin. Lab Invest. 1985;52:611-616.
45. Weinstat-Saslow DL, Zabrenetzky VS, Van Houtte K, Frazier WA, Robert DD, Steeg PS. Transfection of thrombospondin 1 cDNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res. 1994;54: 6504-6511.
46. RayChaudhury A, Frazier WA, D'Amore PA. Comparison of normal and tumorigenic cells: differences in thrombospondin production and responses to transforming growth factor-beta. J Cell Sci. 1994;107: 39-46.
47. Canfield AE, Schor AM, Schor SL, Grant ME. The biosynthesis of extracellular-matrix components by bovine retinal endothelial cells displaying distinctive morphological phenotypes. Biochem J. 1986; 235:375-383.
48. Murphy-Ullrich JE, Hook M. Thrombospondin modulates focal adhesions in endothelial cells. J Cell Biol. 1989;109:1309-1319.
49. Majack RA, Goodman LV, Dixit VM. Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J Cell Biol. 1988;106:415-422.
50. Majack RA, Mildbrandt J, Dixit VM. Induction of thrombospondin messenger RNA levels occurs as an immediate primary response to platelet-derived growth factor. J Biol Chem. 1987;262:8821-8825.
51. Majack RA, Cook SC, Bornstein P. Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J Cell Biol. 1985;101:1059-1071.
52. Haudenschild CC, Schwartz SM. Endothelial regeneration, II: restitution of endothelial continuity. Lab Invest. 1979;41:407-418.
53. Clowes AW, Collazzo RE, Karnovsky MJ. A morphologic and permeability study of luminal smooth muscle cells after arterial injury in the rat. Lab Invest. 1978;39:141-150.
54. Fishman JA, Ryan GB, Karnovsky MJ. Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening. Lab Invest. 1975;32:339-351.
55. Bjorkerud S, Bondjers G. Arterial repair and atherosclerosis after mechanical injury, V: tissue response after induction of a large superficial transverse injury. Atherosclerosis. 1973;18:235-255.
56. Bjornsson TD, Dryjski M, Tluczek J, Mennie R, Ronan J, Mellin TN, Thomas KA. Acidic fibroblast growth factor promotes vascular repair. Proc Natl Acad Sci U S A. 1991;88:8651-8655.
57. Meurice T, Bauters C, Auffray JL, Vallet B, Hamon M, Valero F, Von Belle E, Lablanche JM, Bertrand ME. Basic fibroblast growth factor restores endothelium-dependent responses after balloon injury of rabbit arteries. Circulation. 1996;93:18-22.